Form4insider filings, from the source

Company · CIK 0001645460 · SIC 2834 — Pharmaceutical Preparations · Nasdaq

Cue Biopharma, Inc. · CUE

Insider activity reported against this company. All insider holders · On EDGAR ↗

1M3M6M1Y2YAll datashares as filed — not split-adjusted
Open-market buys & salesbuys $0 · 0sales $2.0M · 3net −$2.0M
$10k$10k$100k$100k$1M$1M$10M$10MbuyssalesJun 28Jul 13Jul 28Aug 13Aug 28Sep 13Sep 28

Reported at this company — common stock

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Aug 13, 2026 SForm 4 →Aug 17, 6:22 pm EDTSumita RayChief Legal Compliance Officer8,829$30.09$265,628118,545−6.93%
Aug 13, 2026 MForm 4 →Aug 17, 6:22 pm EDTSumita RayChief Legal Compliance Officer18,196——127,374—
Aug 13, 2026 SForm 4 →Aug 17, 6:19 pm EDTMichael Vincent MeluzioVP, Prin. Accounting Officer5,628$30.09$169,32448,961−10.3%
Aug 13, 2026 MForm 4 →Aug 17, 6:19 pm EDTMichael Vincent MeluzioVP, Prin. Accounting Officer13,647——54,589—
Aug 12, 2026 SForm 4 →Aug 14, 8:46 pm EDTShao-Lee LinChief Executive Officer, Director58,258$27.58$1,606,562705,995−7.62%
Aug 12, 2026 MForm 4 →Aug 14, 8:46 pm EDTShao-Lee LinChief Executive Officer, Director109,179——764,253—
Jul 30, 2026 AForm 4 →Aug 3, 4:19 pm EDTJames M AhlersChief Financial Officer25,500——25,500—
Jul 13, 2026 AForm 4 →Jul 15, 6:59 pm EDTDominique Christian BorieChief Medical Officer31,500——31,500—
Jul 9, 2026 AForm 4/A →Aug 28, 5:05 pm EDTPasha SarrafDirector18,400——29,195—
Jul 9, 2026 AForm 4/A →Aug 28, 5:04 pm EDTPamela GarzoneDirector18,900——18,900—
Jul 9, 2026 AForm 4 →Jul 10, 7:37 pm EDTPamela GarzoneDirector21,800——21,800— amended
Jul 9, 2026 AForm 4 →Jul 10, 7:37 pm EDTDaniel A. CamardoDirector21,800——21,800—
Jul 9, 2026 AForm 4 →Jul 10, 7:36 pm EDTPasha SarrafDirector21,800——32,595— amended
Jul 9, 2026 AForm 4 →Jul 10, 7:35 pm EDTViola Mong MeehanDirector21,800——21,800—
Jul 9, 2026 AForm 4 →Jul 10, 7:34 pm EDTMichael Vincent MeluzioVP, Prin. Accounting Officer40,942——40,942—
Jul 9, 2026 AForm 4 →Jul 10, 7:33 pm EDTSumita RayChief Legal Compliance Officer54,589——109,178—
Jul 9, 2026 AForm 4 →Jul 10, 7:32 pm EDTShao-Lee LinChief Executive Officer, Director327,537——655,074—

Reported at this company — derivatives (options, RSUs, warrants)

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Aug 13, 2026 MForm 4 →Aug 17, 6:22 pm EDTSumita RayChief Legal Compliance Officer18,196——36,393—
Aug 13, 2026 MForm 4 →Aug 17, 6:19 pm EDTMichael Vincent MeluzioVP, Prin. Accounting Officer13,647——27,295—
Aug 12, 2026 MForm 4 →Aug 14, 8:46 pm EDTShao-Lee LinChief Executive Officer, Director109,179——218,358—
Jul 30, 2026 AForm 4 →Aug 3, 4:19 pm EDTJames M AhlersChief Financial Officer51,000——51,000—
Jul 13, 2026 AForm 4 →Jul 15, 6:59 pm EDTDominique Christian BorieChief Medical Officer63,000——63,000—
Jul 9, 2026 AForm 4 →Jul 10, 7:34 pm EDTMichael Vincent MeluzioVP, Prin. Accounting Officer40,942——40,942—
Jul 9, 2026 AForm 4 →Jul 10, 7:33 pm EDTSumita RayChief Legal Compliance Officer54,589——54,589—
Jul 9, 2026 AForm 4 →Jul 10, 7:32 pm EDTShao-Lee LinChief Executive Officer, Director327,537——327,537—